Coagulation, Microenvironment and Liver Fibrosis

Fibrosis is the main consequence of any kind of chronic liver damage. Coagulation and thrombin generation are crucial in the physiological response to tissue injury; however, the inappropriate and uncontrolled activation of coagulation cascade may lead to fibrosis development due to the involvement...

Full description

Bibliographic Details
Main Authors: Niccolò Bitto, Eleonora Liguori, Vincenzo La Mura
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/7/8/85
id doaj-a745e8ab10964287bc45bbbcbb8769c0
record_format Article
spelling doaj-a745e8ab10964287bc45bbbcbb8769c02020-11-24T22:22:57ZengMDPI AGCells2073-44092018-07-01788510.3390/cells7080085cells7080085Coagulation, Microenvironment and Liver FibrosisNiccolò Bitto0Eleonora Liguori1Vincenzo La Mura2Medicina Interna, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Donato, Università Degli Studi di Milano, 20097 San Donato Milanese (MI), ItalyMedicina Interna, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Donato, Università Degli Studi di Milano, 20097 San Donato Milanese (MI), ItalyFondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, UOC Medicina Generale-Emostasi e Trombosi, 20122 Milano, ItalyFibrosis is the main consequence of any kind of chronic liver damage. Coagulation and thrombin generation are crucial in the physiological response to tissue injury; however, the inappropriate and uncontrolled activation of coagulation cascade may lead to fibrosis development due to the involvement of several cellular types and biochemical pathways in response to thrombin generation. In the liver, hepatic stellate cells and sinusoidal endothelial cells orchestrate fibrogenic response to chronic damage. Thrombin interacts with these cytotypes mainly through protease-activated receptors (PARs), which are expressed by endothelium, platelets and hepatic stellate cells. This review focuses on the impact of coagulation in liver fibrogenesis, describes receptors and pathways involved and explores the potential antifibrotic properties of drugs active in hemostasis in studies with cells, animal models of liver damage and humans.http://www.mdpi.com/2073-4409/7/8/85thrombinprotease-activated receptorsendothelial dysfunctionvon Willebrand factorhepatitiscirrhosisanticoagulation
collection DOAJ
language English
format Article
sources DOAJ
author Niccolò Bitto
Eleonora Liguori
Vincenzo La Mura
spellingShingle Niccolò Bitto
Eleonora Liguori
Vincenzo La Mura
Coagulation, Microenvironment and Liver Fibrosis
Cells
thrombin
protease-activated receptors
endothelial dysfunction
von Willebrand factor
hepatitis
cirrhosis
anticoagulation
author_facet Niccolò Bitto
Eleonora Liguori
Vincenzo La Mura
author_sort Niccolò Bitto
title Coagulation, Microenvironment and Liver Fibrosis
title_short Coagulation, Microenvironment and Liver Fibrosis
title_full Coagulation, Microenvironment and Liver Fibrosis
title_fullStr Coagulation, Microenvironment and Liver Fibrosis
title_full_unstemmed Coagulation, Microenvironment and Liver Fibrosis
title_sort coagulation, microenvironment and liver fibrosis
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2018-07-01
description Fibrosis is the main consequence of any kind of chronic liver damage. Coagulation and thrombin generation are crucial in the physiological response to tissue injury; however, the inappropriate and uncontrolled activation of coagulation cascade may lead to fibrosis development due to the involvement of several cellular types and biochemical pathways in response to thrombin generation. In the liver, hepatic stellate cells and sinusoidal endothelial cells orchestrate fibrogenic response to chronic damage. Thrombin interacts with these cytotypes mainly through protease-activated receptors (PARs), which are expressed by endothelium, platelets and hepatic stellate cells. This review focuses on the impact of coagulation in liver fibrogenesis, describes receptors and pathways involved and explores the potential antifibrotic properties of drugs active in hemostasis in studies with cells, animal models of liver damage and humans.
topic thrombin
protease-activated receptors
endothelial dysfunction
von Willebrand factor
hepatitis
cirrhosis
anticoagulation
url http://www.mdpi.com/2073-4409/7/8/85
work_keys_str_mv AT niccolobitto coagulationmicroenvironmentandliverfibrosis
AT eleonoraliguori coagulationmicroenvironmentandliverfibrosis
AT vincenzolamura coagulationmicroenvironmentandliverfibrosis
_version_ 1725766716492873728